학술논문

RENAL OUTCOMES OF HEPARIN AND TOCILIZUMAB IN PATIENTS WITH SEVERE COVID-19: A SUBANALYSIS OF THE HEPMAB RANDOMIZED CLINICAL TRIAL (HEPMAB-AKI).
Document Type
Article
Source
Journal of the American College of Cardiology (JACC). 2024 Supplement, Vol. 83 Issue 13, p2605-2605. 1p.
Subject
*HEPARIN
*CLINICAL trials
*TOCILIZUMAB
Language
ISSN
0735-1097